Showing 311-320 of 352 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D) | University of Washington | Petter Bjornstad | Improving Lives | 01-September-2025 to 31-August-2028 | $2,040,014.30 |
| Promoting functional maturation of SC-derived beta-cells by novel Epigenetic regulators | University of Washington | Vincenzino Cirulli | Cures | 01-October-2024 to 30-September-2026 | $500,000.00 |
| microRNAs as regulators of stem cell differentiation into islet cells | University of Washington | Vincenzino Cirulli | Cures | 01-August-2025 to 31-July-2027 | $600,000.00 |
| Single nucleus multiomics temporal profiling of islet immune cells in male and female NOD mice during UPR-deficiency-induced senescence | University of Wisconsin-Madison (Board of Regents University of Wisconsin System) | Feyza Engin | Cures | 01-February-2025 to 31-January-2028 | $750,000.00 |
| Identifying the temporal functions of beta cell UPR in T1D | University of Wisconsin-Madison (Board of Regents University of Wisconsin System) | Feyza Engin | Cures | 01-February-2023 to 31-January-2028 | $750,000.00 |
| Process development for adipose tissue implantation of immune evasive ES-derived islet-like cells | University of Wisconsin-Madison (Board of Regents University of Wisconsin System) | Jacques Galipeau | Cures | 01-January-2026 to 31-December-2027 | $628,883.28 |
| Stem Cell-derived Islet Vascularized Extracellular Matrix Organoids for Enhanced Transplantation Success | University of Wisconsin-Madison (Board of Regents University of Wisconsin System) | Jon Odorico | Cures | 01-January-2024 to 31-December-2026 | $1,394,960.67 |
| ICAM-1 Knock Out Pluripotent Stem Cells for Hypoimmune Type 1 Diabetes Therapy | University of Wisconsin-Madison (Board of Regents University of Wisconsin System) | Matthew Brown | Cures | 01-April-2025 to 31-March-2027 | $699,998.53 |
| Immune-checkpoint engineered beta cells as treatment for T1D | UT Southwestern | Andrew Wang | Cures | 01-October-2023 to 30-September-2026 | $746,818.40 |
| Targeted delivery of therapeutics to islet beta cells for preventing and treating diabetes | UT Southwestern | Juanzhu Yan | Cures | 01-March-2025 to 30-April-2028 | $285,000.00 |